PLx Pharma Winddown Corp.
PLx Pharma Winddown Corp., headquartered in the United States, operates within the pharmaceutical industry, focusing on the development of innovative drug delivery systems. Founded in 2013, the company has made significant strides in enhancing the safety and efficacy of medications, particularly through its proprietary technology that aims to reduce gastrointestinal side effects. The firm is best known for its unique formulations, which include products designed to improve the bioavailability of non-steroidal anti-inflammatory drugs (NSAIDs). PLx Pharma has established a notable market position, recognised for its commitment to advancing patient care through scientific innovation. As the company transitions into winddown, its legacy in the pharmaceutical sector remains impactful, reflecting a dedication to improving therapeutic outcomes.
DitchCarbon Score
How does PLx Pharma Winddown Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PLx Pharma Winddown Corp.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PLx Pharma Winddown Corp.'s reported carbon emissions
PLx Pharma Winddown Corp., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and climate commitments suggests that PLx Pharma Winddown Corp. may not have established a formal framework for addressing its carbon footprint or engaging in sustainability initiatives. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of climate action and transparency in emissions reporting. However, without specific commitments or inherited data from a parent organisation, PLx Pharma Winddown Corp. appears to be at a standstill regarding its climate strategy. As the industry evolves, it may be beneficial for the company to consider developing measurable targets and initiatives to align with broader environmental goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PLx Pharma Winddown Corp. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
